companydata.dkAfyx Development A/S: Financial statements 2023
CVR: 35839739
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -4,707,963 and a net result of DKK -9,990,744 compared with DKK -24,274,950 the year before. Equity amounted to DKK 2,402,755. The solvency ratio was 53.3%. The company had 3 employees in the financial year.
- Gross Profit
- -4,707,963 kr.
- Profit/Loss
- -9,990,744 kr.
- Equity
- 2,402,755 kr.
- Total Assets
- 4,511,295 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -4.7 mio. | -10 mio. | 2.4 mio. | 3 |
| 2022 | - | -8.6 mio. | -24.3 mio. | -112.3 mio. | 3 |
| 2021 | - | -27.4 mio. | -35 mio. | -88 mio. | 6 |
| 2020 | - | -36.2 mio. | -49.5 mio. | -53 mio. | 10 |
| 2019 | - | -52.5 mio. | -57.7 mio. | -3.5 mio. | 10 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Afyx Development A/S has published its annual report for 2022. Gross profit came to DKK -8,601,049, and the net result was DKK -24,274,950.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The company is owned by Afyx Therapeutics A/S. The company has 8 employees. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity amounted to DKK -7,253,987.